SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Cars.com
CARS
Hutchmed (China)
HCM
Halozyme Therapeutics
HALO
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -30.05%596M | -18.16%604M | -8.58%746M | 9.17%1.2B | 9.17%1.2B | -26.99%852M | -40.87%738M | -28.73%816M | -24.05%1.1B | -24.05%1.1B |
-Cash and cash equivalents | -30.05%596M | -18.16%604M | -8.58%746M | 9.17%1.2B | 9.17%1.2B | -26.99%852M | -40.87%738M | -28.73%816M | -24.05%1.1B | -24.05%1.1B |
Receivables | 12.41%951M | 0.67%896M | -5.38%792M | -2.56%610M | -2.56%610M | -13.67%846M | -16.51%890M | -17.46%837M | -13.06%626M | -13.06%626M |
-Accounts receivable | 9.56%825M | 0.77%788M | -4.16%692M | 0.00%509M | 0.00%509M | -10.78%753M | -15.28%782M | -18.33%722M | -20.96%509M | -20.96%509M |
-Taxes receivable | 43.06%103M | -5.43%87M | -7.95%81M | -7.95%81M | -7.95%81M | 4.35%72M | 64.29%92M | 46.67%88M | 114.63%88M | 114.63%88M |
-Other receivables | 9.52%23M | 31.25%21M | -29.63%19M | -31.03%20M | -31.03%20M | -68.66%21M | -81.61%16M | -61.43%27M | -17.14%29M | -17.14%29M |
Inventory | 9.44%1.44B | -5.39%1.37B | -6.39%1.39B | -3.70%1.35B | -3.70%1.35B | -0.53%1.31B | 18.62%1.45B | 27.44%1.49B | 27.75%1.4B | 27.75%1.4B |
Restricted cash | -96.64%20M | -92.75%15M | --607M | --604M | --604M | --595M | --207M | ---- | --0 | --0 |
Other current assets | -1.32%75M | -15.63%54M | -3.17%61M | -19.51%66M | -19.51%66M | 1.33%76M | -12.33%64M | -7.35%63M | 9.33%82M | 9.33%82M |
Total current assets | -16.37%3.08B | -12.95%2.94B | 12.34%3.6B | 19.32%3.84B | 19.32%3.84B | 3.95%3.68B | -6.43%3.37B | -5.63%3.2B | -3.92%3.21B | -3.92%3.21B |
Non current assets | ||||||||||
Net PPE | 1.48%3.43B | -0.76%3.41B | 1.26%3.46B | 1.91%3.48B | 1.91%3.48B | 2.24%3.38B | 3.09%3.43B | 1.85%3.42B | 0.89%3.41B | 0.89%3.41B |
-Gross PPE | 3.14%9.8B | -1.03%9.69B | -0.16%9.72B | 0.47%9.67B | 0.47%9.67B | 0.88%9.5B | 3.25%9.79B | 2.72%9.74B | 1.78%9.63B | 1.78%9.63B |
-Accumulated depreciation | -4.05%-6.37B | 1.18%-6.28B | 0.93%-6.26B | 0.32%-6.2B | 0.32%-6.2B | -0.15%-6.12B | -3.33%-6.36B | -3.20%-6.32B | -2.27%-6.22B | -2.27%-6.22B |
Goodwill and other intangible assets | -54.21%49M | -4.55%105M | -6.25%105M | -8.70%105M | -8.70%105M | -8.55%107M | -4.35%110M | 4.67%112M | 6.48%115M | 6.48%115M |
-Goodwill | -54.90%46M | 0.00%102M | 0.00%102M | 0.00%102M | 0.00%102M | 0.00%102M | 0.00%102M | 0.00%102M | 0.00%102M | 0.00%102M |
-Other intangible assets | -40.00%3M | -62.50%3M | -70.00%3M | -76.92%3M | -76.92%3M | -66.67%5M | -38.46%8M | 100.00%10M | 116.67%13M | 116.67%13M |
Investments and advances | -1.04%190M | -10.58%169M | -10.81%165M | -9.71%158M | -9.71%158M | 3.23%192M | 6.78%189M | 8.82%185M | 3.55%175M | 3.55%175M |
Non current deferred assets | 20.22%333M | 31.17%303M | 92.95%301M | 99.34%303M | 99.34%303M | 103.68%277M | 35.88%231M | 4.70%156M | -11.11%152M | -11.11%152M |
Defined pension benefit | 30.19%69M | 18.52%64M | 14.81%62M | 14.00%57M | 14.00%57M | 1.92%53M | -3.57%54M | -3.57%54M | -9.09%50M | -9.09%50M |
Other non current assets | 21.62%315M | -1.87%263M | -42.25%287M | -39.39%317M | -39.39%317M | -36.52%259M | -2.55%268M | 69.62%497M | 62.93%523M | 62.93%523M |
Total non current assets | 2.77%4.38B | 0.61%4.31B | -0.93%4.38B | -0.23%4.42B | -0.23%4.42B | 1.50%4.27B | 3.93%4.29B | 7.04%4.42B | 5.26%4.43B | 5.26%4.43B |
Total assets | -6.10%7.46B | -5.37%7.25B | 4.64%7.98B | 8.00%8.25B | 8.00%8.25B | 2.62%7.95B | -0.91%7.66B | 1.33%7.62B | 1.19%7.64B | 1.19%7.64B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 12.50%1.09B | -7.85%951M | -17.51%989M | -5.19%1.19B | -5.19%1.19B | -26.05%968M | -19.63%1.03B | -1.40%1.2B | 3.90%1.25B | 3.90%1.25B |
-accounts payable | 18.11%1.04B | -6.95%911M | -17.78%939M | -6.28%1.13B | -6.28%1.13B | -30.87%878M | -21.62%979M | -2.23%1.14B | 6.05%1.21B | 6.05%1.21B |
-Total tax payable | -42.22%52M | -24.53%40M | -12.28%50M | 26.19%53M | 26.19%53M | 130.77%90M | 51.43%53M | 18.75%57M | -34.38%42M | -34.38%42M |
Current accrued expenses | -60.09%360M | -64.00%302M | 350.00%927M | 331.08%957M | 331.08%957M | 311.87%902M | 405.42%839M | 10.16%206M | 76.19%222M | 76.19%222M |
Current provisions | -13.07%133M | -13.50%141M | -21.98%142M | -27.94%147M | -27.94%147M | -30.77%153M | -34.54%163M | -7.14%182M | 9.09%204M | 9.09%204M |
Current debt and capital lease obligation | 35.90%106M | 15.38%90M | 25.33%94M | 15.22%106M | 15.22%106M | 8.33%78M | 2.63%78M | -2.60%75M | 9.52%92M | 9.52%92M |
-Current debt | 130.43%53M | 48.00%37M | 64.00%41M | 18.60%51M | 18.60%51M | -4.17%23M | 4.17%25M | 4.17%25M | 72.00%43M | 72.00%43M |
-Current capital lease obligation | -3.64%53M | 0.00%53M | 6.00%53M | 12.24%55M | 12.24%55M | 14.58%55M | 1.92%53M | -5.66%50M | -16.95%49M | -16.95%49M |
Current liabilities | -19.04%1.78B | -28.90%1.56B | 27.85%2.23B | 31.46%2.49B | 31.46%2.49B | 12.51%2.2B | 16.12%2.19B | -1.69%1.75B | 1.78%1.89B | 1.78%1.89B |
Non current liabilities | ||||||||||
Long term provisions | -1.68%527M | -4.40%522M | -5.08%523M | -3.47%528M | -3.47%528M | -2.37%536M | 1.87%546M | 22.99%551M | 21.29%547M | 21.29%547M |
Long term debt and capital lease obligation | 0.79%4.18B | 9.11%4.15B | 9.80%4.17B | 10.69%4.19B | 10.69%4.19B | 12.13%4.15B | -0.89%3.8B | -2.14%3.79B | -2.95%3.79B | -2.95%3.79B |
-Long term debt | 1.12%3.99B | 9.63%3.95B | 10.25%3.97B | 11.06%3.99B | 11.06%3.99B | 12.36%3.94B | -1.42%3.6B | -2.52%3.6B | -3.60%3.59B | -3.60%3.59B |
-Long term capital lease obligation | -5.31%196M | -0.51%195M | 1.54%198M | 4.04%206M | 4.04%206M | 7.81%207M | 10.11%196M | 5.41%195M | 10.61%198M | 10.61%198M |
Non current deferred liabilities | -24.07%41M | -29.31%41M | -26.67%44M | -27.87%44M | -27.87%44M | 1.89%54M | 7.41%58M | 15.38%60M | 24.49%61M | 24.49%61M |
Non current accrued expenses | 72.73%114M | 22.03%72M | 33.33%72M | 32.73%73M | 32.73%73M | 29.41%66M | 18.00%59M | 10.20%54M | 10.00%55M | 10.00%55M |
Employee benefits | -27.27%72M | -12.35%71M | -7.41%75M | -8.54%75M | -8.54%75M | 15.12%99M | -10.00%81M | -11.96%81M | -12.77%82M | -12.77%82M |
Other non current liabilities | -1.11%89M | -0.86%115M | 1.80%113M | 3.67%113M | 3.67%113M | 32.35%90M | 78.46%116M | 73.44%111M | 73.02%109M | 73.02%109M |
Total non current liabilities | 0.62%5.03B | 6.59%4.97B | 7.35%4.99B | 8.27%5.03B | 8.27%5.03B | 10.80%5B | 0.67%4.66B | 1.51%4.65B | 0.69%4.64B | 0.69%4.64B |
Total liabilities | -5.38%6.8B | -4.76%6.52B | 12.95%7.22B | 14.99%7.51B | 14.99%7.51B | 11.32%7.19B | 5.14%6.85B | 0.61%6.4B | 1.00%6.53B | 1.00%6.53B |
Shareholders'equity | ||||||||||
Share capital | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M |
-common stock | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M |
Retained earnings | -4.44%1.76B | -1.93%1.83B | -21.12%1.8B | -17.88%1.78B | -17.88%1.78B | -19.92%1.85B | -11.32%1.86B | 17.42%2.28B | 24.28%2.17B | 24.28%2.17B |
Paid-in capital | 1.94%1.05B | 3.06%1.05B | 2.89%1.03B | 1.67%1.03B | 1.67%1.03B | 1.48%1.03B | 0.90%1.01B | 5.02%1B | 7.63%1.02B | 7.63%1.02B |
Less: Treasury stock | -0.11%1.81B | 0.84%1.81B | 3.14%1.81B | 3.91%1.81B | 3.91%1.81B | 12.66%1.81B | 18.00%1.79B | 25.70%1.75B | 39.37%1.74B | 39.37%1.74B |
Gains losses not affecting retained earnings | -12.06%-353M | -23.05%-347M | 10.46%-274M | 20.12%-274M | 20.12%-274M | 27.25%-315M | 25.40%-282M | 9.73%-306M | 5.77%-343M | 5.77%-343M |
Total stockholders'equity | -12.98%657M | -10.52%723M | -38.71%752M | -33.42%737M | -33.42%737M | -41.20%755M | -33.44%808M | 5.23%1.23B | 2.41%1.11B | 2.41%1.11B |
Noncontrolling interests | 0.00%2M | 0.00%2M | 100.00%2M | --2M | --2M | 100.00%2M | 100.00%2M | 0.00%1M | --0 | --0 |
Total equity | -12.95%659M | -10.49%725M | -38.60%754M | -33.24%739M | -33.24%739M | -41.09%757M | -33.33%810M | 5.23%1.23B | 2.31%1.11B | 2.31%1.11B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |